Trial Outcomes & Findings for Dexterous Partial Hand Prosthesis Outcomes (NCT NCT05038566)

NCT ID: NCT05038566

Last Updated: 2025-01-17

Results Overview

During the in-lab portion of the study, subjects will be asked to complete the 'small common objects' subtask of the Jebsen-Taylor Hand Function Test, which assesses a broad range of unimanual hand functions required for ADLs. The primary quantitative measure of the Jebsen-Taylor task will be completion time of each subtask. The maximum time allotted for each task was 120 seconds, at which point the subject was told to stop the task and the time was reported as the maximum 120 seconds. This test will be used to evaluate the feasibility of the device design as compared with a baseline condition. This was the only primary outcome measure collected for this study. There were no secondary outcome measures, only exploratory measures as this is a very early prototype design that is still in the design iteration stages.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

4 participants

Primary outcome timeframe

4 hours at a single site visit

Results posted on

2025-01-17

Participant Flow

Participant milestones

Participant milestones
Measure
Comparator Baseline, Then Pointdexter
The subject wears their usual partial hand prosthesis while performing functional outcome measures. The subject then wears a modified version of their usual partial hand prosthesis. The modification replaces the usual index finger of the partial hand prosthesis with the investigational Pointdexter device. Subjects will test out this hand configuration in the lab while performing functional outcome measures. This testing occurs at a single site visit (1 day) and lasts approximately 4 hours. Pointdexter: i-Digits partial hand prosthesis modified with the investigational pointdexter finger in place of the usual index finger.
Pointdexter, Then Comparator Baseline
The subject wears a modified version of their usual partial hand prosthesis. The modification replaces the usual index finger of the partial hand prosthesis with the investigational Pointdexter device. Subjects will test out this hand configuration in the lab while performing functional outcome measures. The subject then wears their usual partial hand prosthesis while performing functional outcome measures. This testing occurs at a single site visit (1 day) and lasts approximately 4 hours. Pointdexter: i-Digits partial hand prosthesis modified with the investigational pointdexter finger in place of the usual index finger.
Overall Study
STARTED
2
2
Overall Study
COMPLETED
2
1
Overall Study
NOT COMPLETED
0
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Comparator Baseline, Then Pointdexter
The subject wears their usual partial hand prosthesis while performing functional outcome measures. The subject then wears a modified version of their usual partial hand prosthesis. The modification replaces the usual index finger of the partial hand prosthesis with the investigational Pointdexter device. Subjects will test out this hand configuration in the lab while performing functional outcome measures. This testing occurs at a single site visit (1 day) and lasts approximately 4 hours. Pointdexter: i-Digits partial hand prosthesis modified with the investigational pointdexter finger in place of the usual index finger.
Pointdexter, Then Comparator Baseline
The subject wears a modified version of their usual partial hand prosthesis. The modification replaces the usual index finger of the partial hand prosthesis with the investigational Pointdexter device. Subjects will test out this hand configuration in the lab while performing functional outcome measures. The subject then wears their usual partial hand prosthesis while performing functional outcome measures. This testing occurs at a single site visit (1 day) and lasts approximately 4 hours. Pointdexter: i-Digits partial hand prosthesis modified with the investigational pointdexter finger in place of the usual index finger.
Overall Study
Technical Difficulties with the Device
0
1

Baseline Characteristics

Dexterous Partial Hand Prosthesis Outcomes

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Comparator Baseline, Then Pointdexter (~4 Hours of In-lab Testing)
n=2 Participants
The subject wears their usual partial hand prosthesis while performing functional outcome measures. The subject then wears a modified version of their usual partial hand prosthesis. The modification replaces the usual index finger of the partial hand prosthesis with the investigational Pointdexter device. Subjects will either test out this hand configuration in the lab while performing functional outcome measures. The subject may then choose to take home the Pointdexter device for up to 4 weeks for feasibility testing of the early stage prototype device. Pointdexter: i-Digits partial hand prosthesis modified with the investigational pointdexter finger in place of the usual index finger.
Pointdexter, Then Comparator Baseline (~4 Hours of In-lab Testing)
n=2 Participants
The subject wears a modified version of their usual partial hand prosthesis. The modification replaces the usual index finger of the partial hand prosthesis with the investigational Pointdexter device. Subjects will test out this hand configuration in the lab while performing functional outcome measures. The subject then wears their usual partial hand prosthesis while performing functional outcome measures. The subject may then choose to take home the Pointdexter device for up to 4 weeks for feasibility testing of the early stage prototype device. Pointdexter: i-Digits partial hand prosthesis modified with the investigational pointdexter finger in place of the usual index finger.
Total
n=4 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
2 Participants
n=99 Participants
2 Participants
n=107 Participants
4 Participants
n=206 Participants
Age, Categorical
>=65 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Sex: Female, Male
Female
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Sex: Female, Male
Male
2 Participants
n=99 Participants
2 Participants
n=107 Participants
4 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
2 Participants
n=99 Participants
2 Participants
n=107 Participants
4 Participants
n=206 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Asian
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
White
2 Participants
n=99 Participants
2 Participants
n=107 Participants
4 Participants
n=206 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Region of Enrollment
United States
2 Participants
n=99 Participants
2 Participants
n=107 Participants
4 Participants
n=206 Participants

PRIMARY outcome

Timeframe: 4 hours at a single site visit

Population: One participant was excluded from analysis due to an incomplete session because of technical difficulties with the device

During the in-lab portion of the study, subjects will be asked to complete the 'small common objects' subtask of the Jebsen-Taylor Hand Function Test, which assesses a broad range of unimanual hand functions required for ADLs. The primary quantitative measure of the Jebsen-Taylor task will be completion time of each subtask. The maximum time allotted for each task was 120 seconds, at which point the subject was told to stop the task and the time was reported as the maximum 120 seconds. This test will be used to evaluate the feasibility of the device design as compared with a baseline condition. This was the only primary outcome measure collected for this study. There were no secondary outcome measures, only exploratory measures as this is a very early prototype design that is still in the design iteration stages.

Outcome measures

Outcome measures
Measure
Comparator Baseline
n=2 Participants
The subject wears their usual partial hand prosthesis while performing functional outcome measures. Subjects will test out this hand configuration in the lab while performing functional outcome measures. This testing occurs at a single site visit (1 day) and lasts approximately 4 hours.
Pointdexter
n=1 Participants
The subject wears a modified version of their usual partial hand prosthesis. The modification replaces the usual index finger of the partial hand prosthesis with the investigational Pointdexter device. Subjects will test out this hand configuration in the lab while performing functional outcome measures. This testing occurs at a single site visit (1 day) and lasts approximately 4 hours. Pointdexter: i-Digits partial hand prosthesis modified with the investigational pointdexter finger in place of the usual index finger.
Jebsen-Taylor Small Common Objects Functional Test
Large Light Objects
11.7 Seconds
Standard Deviation 4.2
14.3 Seconds
Standard Deviation 3.7
Jebsen-Taylor Small Common Objects Functional Test
Turning a Card Over
34.8 Seconds
Standard Deviation 20.5
26.1 Seconds
Standard Deviation 4.5
Jebsen-Taylor Small Common Objects Functional Test
Small Common Objects
97.2 Seconds
Standard Deviation 32.2
62.1 Seconds
Standard Deviation 2.2
Jebsen-Taylor Small Common Objects Functional Test
Stacking Checkers
37.5 Seconds
Standard Deviation 43.1
28 Seconds
Standard Deviation 21.8
Jebsen-Taylor Small Common Objects Functional Test
Manipulating Cloth
5.4 Seconds
Standard Deviation 1.5
5.8 Seconds
Standard Deviation 1.7
Jebsen-Taylor Small Common Objects Functional Test
Holding a Screw
24.1 Seconds
Standard Deviation 1.8
65.7 Seconds
Standard Deviation 34.7
Jebsen-Taylor Small Common Objects Functional Test
9-Hole Out
11.4 Seconds
Standard Deviation 8.1
23.3 Seconds
Standard Deviation 19
Jebsen-Taylor Small Common Objects Functional Test
9-Hole In
120 Seconds
Standard Deviation 0
63.8 Seconds
Standard Deviation 57.3
Jebsen-Taylor Small Common Objects Functional Test
Removing Pen Cap
5.8 Seconds
Standard Deviation 2.3
7.1 Seconds
Standard Deviation 4.2
Jebsen-Taylor Small Common Objects Functional Test
Tying Shoe Laces
50.5 Seconds
Standard Deviation 49
34.6 Seconds
Standard Deviation 1.1
Jebsen-Taylor Small Common Objects Functional Test
Zipping a Zipper
32.6 Seconds
Standard Deviation 10.2
120 Seconds
Standard Deviation 0
Jebsen-Taylor Small Common Objects Functional Test
Threading a Needle
120 Seconds
Standard Deviation 0
32.4 Seconds
Standard Deviation 8.1
Jebsen-Taylor Small Common Objects Functional Test
Simulated Feeding
30.1 Seconds
Standard Deviation 22
66.3 Seconds
Standard Deviation 76
Jebsen-Taylor Small Common Objects Functional Test
Large Heavy Objects
17.8 Seconds
Standard Deviation 4.6
16.7 Seconds
Standard Deviation 5

Adverse Events

Comparator Baseline

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Pointdexter

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Todd Farrell

Liberating Technologies, Inc.

Phone: 774-233-0873

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place